Search For "indian pharma"
India's proposal at WTO for TRIPS waiver gets support from 57 nations, say
Updated : 5 years, 1 month ago IST
New Delhi [India], February 25 (ANI): As many as 57 members of the World Trade Organization (WTO) have supported India's proposal for Trade-Related Aspects of Intellectual Property Rights (TRIPS) waiver on COVID-19 vaccines, said Union Minister of Railways Piyush Goyal on Thursday.
Read More
Pharma's 3Q profitability improvement starts to taper off: Ind-Ra
Updated : 5 years, 1 month ago IST
Mumbai (Maharashtra) [India], Feb 17 (ANI): India Ratings and Research (Ind-Ra) does not expect Indian pharmaceutical companies to sustain the healthy operating margins reported during 3Q FY21 and 9M FY21.
Read More
Glenmark's consolidated net profit rises by 30.05% to Rs. 2481.79 Mn. in Q
Updated : 5 years, 1 month ago IST
Mumbai (Maharashtra) [India], February 13 (ANI/PRNewswire): Glenmark Pharmaceuticals Limited, a research-led global integrated pharmaceutical company, today announced its financial results for the third quarter ended December 31 of the financial year 2020-21.
Read More
Indian pharma market expected to grow to USD 130 billion by 2030: Gowda
Updated : 5 years, 1 month ago IST
New Delhi [India], February 8 (ANI): Union Minister for Chemicals and Fertilizers, D V Sadananda Gowda said that the Indian pharma market is expected to grow to USD 130 billion by 2030.
Read More
Pharma sector revenue, margins likely to remain healthy in FY22: ICRA
Updated : 5 years, 3 months ago IST
New Delhi [India], December 24 (ANI): With inelastic demand for drugs and resumption of production to the near pre-Covid levels by Q3 FY21, revenue growth for Indian pharmaceutical market is expected to be 7 to 9 per cent in FY21 despite muted growth in Q1 FY21, according to investment infor
Read More
SC issues notice to Centre on plea seeking CBI probe against pharmaceutica
Updated : 5 years, 4 months ago IST
New Delhi [India], October 29 (ANI): The Supreme Court on Thursday issued notice to the Central government on a plea seeking registration of an FIR by the Central Bureau of Investigation (CBI) against ten Indian pharmaceutical firms for manufacturing and selling Remdesivir and Favipiravir al
Read More
Piramal Pharma completes 20 pc growth investment by Carlyle
Updated : 5 years, 5 months ago IST
Mumbai (Maharashtra) [India], Oct 6 (ANI): Piramal Pharma Ltd (PPL) on Tuesday received Rs 3,523 crore on closure of the transaction for 20 per cent equity investment from CA Alchemy Investments, an affiliated entity of CAP V Mauritius, which is an investment fund managed and advised by affi
Read More
Dr Reddy's Laboratories seeks DCGI permission to conduct Phase III trials
Updated : 5 years, 5 months ago IST
New Delhi [India], October 2 (ANI): Indian pharma giant Dr Reddy's Laboratories (DRL) has submitted an application to the Drugs Controller General of India (DCGI) for its approval to perform Phase III clinical trials of the Russian COVID-19 vaccine Sputnik V in India, a government officia
Read More
Credit metrics of leading pharma companies to remain stable: ICRA
Updated : 5 years, 6 months ago IST
New Delhi [India], Sep 26 (ANI): The global demand scenario for Indian pharmaceutical industry is largely expected to remain stable due to inelastic nature of prescription drugs, investment information agency ICRA has said.
Read More
SC adjourns for two weeks plea seeking CBI case against pharma firms
Updated : 5 years, 6 months ago IST
New Delhi [India], September 16 (ANI): The Supreme Court on Wednesday adjourned for two weeks hearing on a plea seeking registration of an FIR by the Central Bureau of Investigation (CBI) against ten Indian pharmaceutical firms for manufacturing and selling Remdesivir and Favipiravir, allege
Read More
Oxford COVID-19 vaccine trials not paused in India, clarifies Serum Instit
Updated : 5 years, 6 months ago IST
New Delhi [India], September 9 (ANI): After AstraZeneca suspended the trials of COVID-19 vaccine in the UK, Indian pharmaceutical giant Serum Institue of India (SII) on Wednesday clarified that testing of the possible vaccine candidate in India is ongoing and has not faced any issue so far.
Read More
Indian pharma's sales to rise after cost cuts support margins in pandemic-
Updated : 5 years, 7 months ago IST
Mumbai (Maharashtra) [India], Aug 29 (ANI): Indian pharmaceutical companies' sales will rise after a gradual easing of the coronavirus pandemic-related lockdown measures that caused disruptions across most markets in April to June, Fitch Ratings has said.
Read More